MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
|
Back to Search Results |
|
Model Number ETBF3220C166EE |
Device Problem
Device Contamination with Chemical or Other Material (2944)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/06/2023 |
Event Type
malfunction
|
Event Description
|
An endurant ii stent graft was intended to be implanted in a patient for the endovascular treatment of a 47mm abdominal aortic aneurysm.The proximal aortic neck diameter measured 28mm and 25mm in length with a 10 degree neck angulation.Low vessel calcification and tortuosity were noted.It was reported during the index procedure, the physician pushed the bifurcate graft proximal in the patients aorta and detected something in the x - ray which seemed to be inside of the contralateral limb.The physician removed the delivery system but was unable to see anything and decided not to use this main body.An additional endurant ii bifurcate (esbf3214c103ee) and endurant ii limb (etlw1620c124ee) were implanted and the procedure successfully completed with no adverse effects to the patient.After the operation, the physician released the stent (etbf3220c166ee (b)(4)) outside of the patient.Inside the contralateral limb the lower part of the tip capture system, the spindle was found.Per the physician the cause of the spindle detachment is undetermined.No additional clinical sequelae were reported and the patient is fine.
|
|
Manufacturer Narrative
|
Device evaluation summary: a series of six (6) images were received from the account.The images show graft prior to deployment.Two images show the spindle still attached to the spiral member post deployment of the graft.The loading hook is visible following removal from the graft contralateral limb post deployment.The reported foreign material was confirmed through image review.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Film evaluation summary: the reported event was confirmed on the film provided; however, the type of the radiopaque structure observed was most likely a loading hook.The cause of the event could not be determined.Device evaluation summary: a series of six (6) images were received from the account.The images show graft prior to deployment.Two images show the spindle still attached to the spiral member post deployment of the graft.The loading hook is visible following removal from the graft contralateral limb post deployment.The reported foreign material was confirmed through image review.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|